Cargando…
Inhibiting microcephaly genes as alternative to microtubule targeting agents to treat brain tumors
Medulloblastoma (MB) and gliomas are the most frequent high-grade brain tumors (HGBT) in children and adulthood, respectively. The general treatment for these tumors consists in surgery, followed by radiotherapy and chemotherapy. Despite the improvement in patient survival, these therapies are only...
Autores principales: | Iegiani, Giorgia, Di Cunto, Ferdinando, Pallavicini, Gianmarco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523548/ https://www.ncbi.nlm.nih.gov/pubmed/34663805 http://dx.doi.org/10.1038/s41419-021-04259-6 |
Ejemplares similares
-
The impact of TP53 activation and apoptosis in primary hereditary microcephaly
por: Iegiani, Giorgia, et al.
Publicado: (2023) -
Precision Revisited: Targeting Microcephaly Kinases in Brain Tumors
por: Pallavicini, Gianmarco, et al.
Publicado: (2019) -
CENPE Inhibition Leads to Mitotic Catastrophe and DNA Damage in Medulloblastoma Cells
por: Iegiani, Giorgia, et al.
Publicado: (2021) -
CITK Loss Inhibits Growth of Group 3 and Group 4 Medulloblastoma Cells and Sensitizes Them to DNA-Damaging Agents
por: Pallavicini, Gianmarco, et al.
Publicado: (2020) -
Lestaurtinib inhibits Citron kinase activity and medulloblastoma growth through induction of DNA damage, apoptosis and cytokinesis failure
por: Pallavicini, Gianmarco, et al.
Publicado: (2023)